EA200501666A1 - Композиция для улучшения познавательной способности и памяти - Google Patents
Композиция для улучшения познавательной способности и памятиInfo
- Publication number
- EA200501666A1 EA200501666A1 EA200501666A EA200501666A EA200501666A1 EA 200501666 A1 EA200501666 A1 EA 200501666A1 EA 200501666 A EA200501666 A EA 200501666A EA 200501666 A EA200501666 A EA 200501666A EA 200501666 A1 EA200501666 A1 EA 200501666A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- deterioration
- melatonin
- memory
- insomnia
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Abstract
Изобретение относится к фармакологически активной комбинации, применяемой при лечении больных, страдающих бессонницей, которая включает: (а) по меньшей мере один первый активный ингредиент, выбираемый из мелатонина, других мелатонергических агентов, агонистов мелатонина и антагонистов мелатонина; и (б) по меньшей мере один второй активный ингредиент, выбираемый из никотина и агонистов никотиновых рецепторов; к применению медикамента, содержащего компонент (а) с компонентом (б) или без него, для облегчения по меньшей мере одного отрицательного действия, выбираемого из ухудшения качества сна, ухудшения познавательной функции и ухудшения запоминающей функции, которое имеет место у больного в присутствии или отсутствии никотиновой заместительной терапии, а также к комплекту, применяемому для лечения больных, страдающих бессонницей, который включает компоненты (а) и (б) в форме разовой дозы.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL155666A IL155666A (en) | 2003-04-29 | 2003-04-29 | Insomnia treatment |
PCT/IL2004/000330 WO2004096118A2 (en) | 2003-04-29 | 2004-04-15 | Composition for improving cognition and memory |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200501666A1 true EA200501666A1 (ru) | 2006-06-30 |
EA008768B1 EA008768B1 (ru) | 2007-08-31 |
Family
ID=33397641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200501666A EA008768B1 (ru) | 2003-04-29 | 2004-04-15 | Композиция для улучшения познавательной способности и памяти |
Country Status (29)
Country | Link |
---|---|
US (2) | US8859593B2 (ru) |
EP (1) | EP1620058B1 (ru) |
JP (2) | JP4981440B2 (ru) |
KR (1) | KR101136885B1 (ru) |
CN (1) | CN1787820B (ru) |
AR (1) | AR048370A1 (ru) |
AT (1) | ATE539746T1 (ru) |
BR (1) | BRPI0409935A (ru) |
CA (1) | CA2521182C (ru) |
CL (1) | CL2004000877A1 (ru) |
CY (1) | CY1112689T1 (ru) |
DK (1) | DK1620058T3 (ru) |
EA (1) | EA008768B1 (ru) |
ES (1) | ES2380364T3 (ru) |
HK (1) | HK1087635A1 (ru) |
IL (1) | IL155666A (ru) |
IS (1) | IS8090A (ru) |
MX (1) | MXPA05011590A (ru) |
NO (1) | NO333015B1 (ru) |
NZ (1) | NZ542724A (ru) |
PE (1) | PE20050144A1 (ru) |
PL (1) | PL1620058T3 (ru) |
PT (1) | PT1620058E (ru) |
SI (1) | SI1620058T1 (ru) |
TW (1) | TWI340037B (ru) |
UA (1) | UA87980C2 (ru) |
UY (1) | UY28296A1 (ru) |
WO (1) | WO2004096118A2 (ru) |
ZA (1) | ZA200509508B (ru) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL155666A (en) * | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
JP4993900B2 (ja) * | 2005-11-28 | 2012-08-08 | 国立大学法人 東京医科歯科大学 | 記憶障害抑制剤 |
US8372876B2 (en) * | 2007-03-06 | 2013-02-12 | The University Of Houston System | Method for improving memory in mammals |
AU2008228903B2 (en) | 2007-03-19 | 2013-03-07 | Vita Sciences, Llc | Transdermal patch and method for delivery of vitamin B12 |
MX2009011002A (es) | 2007-04-12 | 2010-03-15 | Univ Minnesota | Composiciones de proteccion de isquemia/reperfusion y metodos de uso. |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
KR102317399B1 (ko) | 2012-01-26 | 2021-10-26 | 반다 파마슈티칼즈, 인코퍼레이티드. | 일주기 리듬 장애의 치료 |
CN105142630A (zh) * | 2012-12-18 | 2015-12-09 | 万达制药公司 | 昼夜节律紊乱的治疗 |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
ES2738633T3 (es) * | 2015-02-04 | 2020-01-24 | Soeur Josefa Menendez | Sistema terapéutico transdérmico que contiene valentonina y su uso como medicamento |
US10307398B2 (en) | 2016-09-20 | 2019-06-04 | Regents Of The University Of Minnesota | Resuscitation composition and methods of making and using |
US10849856B2 (en) | 2016-10-31 | 2020-12-01 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
EP3777842A1 (en) | 2016-10-31 | 2021-02-17 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
KR102499141B1 (ko) * | 2016-10-31 | 2023-02-13 | 신신제약 주식회사 | 수면장애 치료용 경피흡수제제 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US468017A (en) * | 1892-02-02 | Lock-case | ||
US4506080A (en) * | 1983-07-01 | 1985-03-19 | Nestec S. A. | Preparation of serotonine and derivatives |
US4965074A (en) * | 1985-03-05 | 1990-10-23 | Ciba-Geigy Corporation | Method of treating memory impairment |
US4765985A (en) * | 1985-03-05 | 1988-08-23 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
US4680172A (en) * | 1985-03-05 | 1987-07-14 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
ATE71287T1 (de) * | 1986-06-13 | 1992-01-15 | Alza Corp | Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit. |
DE3639418A1 (de) | 1986-11-18 | 1988-06-09 | Forschungsgesellschaft Rauchen | Nikotinhaltiges mittel |
CA2116036A1 (en) * | 1991-10-18 | 1993-04-29 | F. Eugene Yates | Device for the transdermal administration of melatonin |
WO1993014200A1 (en) * | 1992-01-07 | 1993-07-22 | Tsi Corporation | Transgenic animal models for alzheimer's disease |
ATE141051T1 (de) * | 1992-04-07 | 1996-08-15 | Neurim Pharma 1991 | Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie |
US5449683A (en) * | 1992-10-01 | 1995-09-12 | Massachussetts Institute Of Technology | Methods of inducing sleep using melatonin |
GB9310412D0 (en) * | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
AU7323794A (en) * | 1993-07-09 | 1995-02-06 | Cygnus Therapeutic Systems | Method and device for providing nicotine replacement therapy transdermally/transbuccally |
WO1995028144A1 (en) * | 1994-04-13 | 1995-10-26 | Ciba-Geigy Ag | Temporally controlled drug delivery systems |
US6017887A (en) * | 1995-01-06 | 2000-01-25 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
WO1996023496A1 (en) | 1995-02-01 | 1996-08-08 | Neurim Pharmaceuticals (1991) Ltd. | Use of melatonin for treating patients suffering from drug addiction |
US5696115A (en) * | 1995-04-21 | 1997-12-09 | Eli Lilly And Company | Method for treating nicotine withdrawal |
US5700828A (en) * | 1995-12-07 | 1997-12-23 | Life Resuscitation Technologies, Inc. | Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions |
EP0906089B1 (en) | 1996-05-13 | 2003-08-27 | Novartis Consumer Health S.A. | Buccal delivery system |
FR2762993B1 (fr) * | 1997-05-06 | 1999-08-13 | Inst Rech Biolog Sa | Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique |
JP2002500652A (ja) * | 1997-05-30 | 2002-01-08 | ニューロサーアチ・アクティーゼルスカブ | スピロ−キヌクリジン誘導体、その製造方法及びその使用方法 |
US6274615B1 (en) * | 1998-03-25 | 2001-08-14 | South Alabama Medical Science Foundation | Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disorders |
AU5787999A (en) | 1998-08-26 | 2000-03-21 | Andrei Zakharovich Afanasiev | Method for treating neurodegenerative disorders |
RU2134108C1 (ru) | 1998-10-06 | 1999-08-10 | Заславская Рина Михайловна | Средство для лечения артериальной гипертонии, способ лечения артериальной гипертонии |
FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
ATE252380T1 (de) * | 1999-02-05 | 2003-11-15 | Cipla Ltd | Topische sprays enthaltend eine filmbildende zusammensetzung |
US6353051B1 (en) * | 1999-03-10 | 2002-03-05 | E. I. Du Pont De Nemours And Company | Top coating for synthetic leathers |
EP1272177B1 (en) | 2000-01-05 | 2007-04-11 | Neurim Pharmaceuticals (1991) Limited | Method and formulation for treating resistance to antihypertensives and related conditions |
PT1311272E (pt) * | 2000-03-03 | 2007-02-28 | Eisai R&D Man Co Ltd | Novos métodos utilizando inibidores de colinesterase |
DE10013712A1 (de) | 2000-03-20 | 2001-09-27 | Nutrinova Gmbh | Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung |
US6486172B2 (en) * | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
BR0208382A (pt) | 2001-03-26 | 2004-06-15 | Smithkline Beecham Corp | Forma de dosagem oral contendo nicotina |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
EP1304048B1 (en) * | 2001-10-22 | 2004-09-22 | Ivo Pera | Composition to reduce or quit smoking addiction |
US7113651B2 (en) * | 2002-11-20 | 2006-09-26 | Dmetrix, Inc. | Multi-spectral miniature microscope array |
IL155666A (en) * | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
-
2003
- 2003-04-29 IL IL155666A patent/IL155666A/en active IP Right Grant
-
2004
- 2004-04-15 WO PCT/IL2004/000330 patent/WO2004096118A2/en active Application Filing
- 2004-04-15 BR BRPI0409935-4A patent/BRPI0409935A/pt not_active Application Discontinuation
- 2004-04-15 CA CA2521182A patent/CA2521182C/en not_active Expired - Lifetime
- 2004-04-15 EP EP04727667A patent/EP1620058B1/en not_active Expired - Lifetime
- 2004-04-15 DK DK04727667.0T patent/DK1620058T3/da active
- 2004-04-15 JP JP2006507610A patent/JP4981440B2/ja not_active Expired - Lifetime
- 2004-04-15 US US10/555,011 patent/US8859593B2/en active Active
- 2004-04-15 ES ES04727667T patent/ES2380364T3/es not_active Expired - Lifetime
- 2004-04-15 AT AT04727667T patent/ATE539746T1/de active
- 2004-04-15 PT PT04727667T patent/PT1620058E/pt unknown
- 2004-04-15 PL PL04727667T patent/PL1620058T3/pl unknown
- 2004-04-15 SI SI200431850T patent/SI1620058T1/sl unknown
- 2004-04-15 UA UAA200511154A patent/UA87980C2/ru unknown
- 2004-04-15 MX MXPA05011590A patent/MXPA05011590A/es active IP Right Grant
- 2004-04-15 EA EA200501666A patent/EA008768B1/ru unknown
- 2004-04-15 CN CN2004800113428A patent/CN1787820B/zh not_active Expired - Lifetime
- 2004-04-15 KR KR1020057020416A patent/KR101136885B1/ko active IP Right Grant
- 2004-04-15 NZ NZ542724A patent/NZ542724A/en unknown
- 2004-04-22 AR ARP040101363A patent/AR048370A1/es unknown
- 2004-04-26 CL CL200400877A patent/CL2004000877A1/es unknown
- 2004-04-28 PE PE2004000418A patent/PE20050144A1/es not_active Application Discontinuation
- 2004-04-28 TW TW093111816A patent/TWI340037B/zh active
- 2004-04-29 UY UY28296A patent/UY28296A1/es not_active Application Discontinuation
-
2005
- 2005-10-25 IS IS8090A patent/IS8090A/is unknown
- 2005-11-23 NO NO20055531A patent/NO333015B1/no unknown
-
2006
- 2006-07-17 HK HK06107940.0A patent/HK1087635A1/xx not_active IP Right Cessation
- 2006-11-24 ZA ZA200509508A patent/ZA200509508B/xx unknown
-
2012
- 2012-02-08 JP JP2012025361A patent/JP2012116859A/ja active Pending
- 2012-04-02 CY CY20121100327T patent/CY1112689T1/el unknown
-
2014
- 2014-09-10 US US14/482,275 patent/US20140378512A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055531L (no) | Preparat for forbedret kognisjon og hukommelse | |
CY1124763T1 (el) | Μεθοδος για την θεραπευτικη αντιμετωπιση της πρωτοπαθους αϋπνιας | |
EA200600820A1 (ru) | Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина | |
ATE457166T1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
ATE302003T1 (de) | Zubereitungen enthaltend apomorphin und sildenafil und ihre verwendung zur behandlung von erektiler dysfunktion | |
DK1742624T3 (da) | Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet | |
TW200616608A (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
EA200801243A1 (ru) | Фармацевтическое применение замещенных амидов | |
MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
HUP0301122A2 (hu) | Gyógyszerkombinációk és gasztrointesztinális rendellenességek kezelésében való alkalmazásuk | |
ATE405272T1 (de) | Behandlung von t-zellen-lymphom mittels 10- propargyl-10-deazaaminopterin | |
SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
DE602004031631D1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
TW200503683A (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
RU2002124141A (ru) | Применение миртазапина для лечения расстройств сна | |
DE60204694D1 (de) | Kombinationstherapie zur behandlung von herzinsuffizienz | |
GEP201606538B (en) | Preoperative treatment of post operative pain | |
ATE431147T1 (de) | Mittel zur behandlung des integrationsdysfunktionssyndroms | |
BRPI0414112A (pt) | uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono | |
TH70531B (th) | องค์ประกอบสำหรับปรับปรุงกระบวนการรับรู้และความจำให้ดีขึ้น | |
TH69871A (th) | องค์ประกอบสำหรับปรับปรุงกระบวนการรับรู้และความจำให้ดีขึ้น | |
RU2010144554A (ru) | Средство для предотвращения и/или лечения сосудистых заболеваний | |
BR0301633A (pt) | Composição farmacêutica empregando steviosìdeo | |
RU2010143898A (ru) | Противоопухолевое средство, включающее производное цитидина и карбоплатин |